ストックスクリーナーアプリを入手
0.00
100.00%
-2.0301
前日終値:
$2.0301
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$35.38M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$2.98
Mural Oncology Plc Stock (MURA) Company Profile
Compare MURA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
0.00 | 35.38M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
437.67 | 111.05B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.58 | 79.01B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
793.22 | 50.08B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.58 | 41.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.41 | 34.67B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
Aug Fed Impact: Is Mural Oncology plc exposed to political risk2026 Volatility Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Guidance Update: What is the PEG ratio of Mural Oncology plcMarket Growth Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Portfolio Shifts: What is the next catalyst for Mural Oncology plcMarket Risk Analysis & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Buybacks Report: Is Mural Oncology plc part of any ETF2026 Analyst Calls & Intraday High Probability Alerts - baoquankhu1.vn
MACD Signal: Can Mural Oncology plc be the next market leader2026 Price Momentum & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Weekly Trades: What is the next catalyst for Mural Oncology plc2026 Market Sentiment & Smart Investment Allocation Insights - baoquankhu1.vn
Merger Talk: Can Mural Oncology plc deliver alphaEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Sentiment Recap: Is Mural Oncology plc exposed to political riskEarnings Beat & Daily Price Action Insights - baoquankhu1.vn
If You Invested $1,000 in Mural Oncology PLC (MURA) - Stock Titan
Analyst Calls: What is the next catalyst for Mural Oncology plcQuarterly Earnings Summary & Verified Technical Signals - baoquankhu1.vn
Quarterly Trades: Should I hold or sell Mural Oncology plc now2025 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Bull Run: Can Mural Oncology plc be the next market leaderJuly 2025 Intraday Action & Fast Moving Stock Watchlists - baoquankhu1.vn
Market Review: Should I hold or sell Mural Oncology plc nowDollar Strength & Growth-Oriented Investment Plans - baoquankhu1.vn
Will Mural Oncology plc stock continue upward momentumJuly 2025 Action & Real-Time Sentiment Analysis - mfd.ru
MURA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
History Review: Can Mural Oncology plc be the next market leaderJuly 2025 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan
What is the next catalyst for Mural Oncology plcQuarterly Investment Review & Safe Capital Investment Plans - mfd.ru
Will Mural Oncology plc benefit from rising consumer demandInflation Watch & Weekly Watchlist for Hot Stocks - mfd.ru
Is Mural Oncology plc’s ROE strong enough2025 Trade Ideas & Free Community Consensus Stock Picks - mfd.ru
Biotech royalty player XOMA lines up March investor talks - Stock Titan
Profit Review: Can Mural Oncology plc beat the S P 5002025 Investor Takeaways & Long-Term Safe Return Strategies - baoquankhu1.vn
Will Mural Oncology plc stock benefit from AI adoptionDip Buying & Short-Term High Return Ideas - mfd.ru
What is Mural Oncology plc’s market positionShort Setup & Long-Term Safe Investment Plans - mfd.ru
Can Mural Oncology plc deliver alphaWeekly Risk Summary & Real-Time Stock Price Movement Reports - mfd.ru
Is Mural Oncology plc stock oversold or undervalued2025 Key Lessons & Risk Managed Investment Signals - mfd.ru
Generation Bio investors cashed out at $4.2913 a share in XOMA takeover - Stock Titan
Resistance Check: What is the next catalyst for Mural Oncology plcJuly 2025 Chart Watch & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Aug EndMonth: Is Mural Oncology plc part of any ETFJuly 2025 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Update Report: What is the next catalyst for Mural Oncology plc2025 Volatility Report & Daily Stock Trend Reports - baoquankhu1.vn
Is Mural Oncology plc affected by consumer sentimentTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn
Mural Oncology To Be Acquired By Xoma Royalty - MSN
Growth Review: Is Mural Oncology plc exposed to political riskDollar Strength & Verified High Yield Trade Plans - baoquankhu1.vn
RSI Check: Should I hold or sell Mural Oncology plc now2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Hedge Fund Moves: What are the future prospects of Brookfield Property Partners LPJuly 2025 Action & Risk Controlled Swing Alerts - baoquankhu1.vn
Mural Oncology PLC (NASDAQ:MURA) Receives $12.00 Consensus PT from Brokerages - Defense World
Risk Check: Is Mural Oncology plc affected by consumer sentimentCEO Change & Expert Curated Trade Ideas - baoquankhu1.vn
Biotech royalty firm XOMA shifts finance leadership after nearly 20 years - Stock Titan
Will Mural Oncology plc stock outperform value stocks2025 AllTime Highs & Low Risk Entry Point Guides - ulpravda.ru
Will Mural Oncology plc stock outperform Nasdaq indexQuarterly Risk Review & AI Powered Trade Plan Recommendations - Улправда
Is Mural Oncology plc stock positioned for digital transformationQuarterly Profit Report & Community Consensus Picks - Улправда
How Mural Oncology plc stock compares to growth peersDollar Strength & Breakout Confirmation Alerts - ulpravda.ru
Retail Trends: Is Mural Oncology plc stock positioned for digital transformationGlobal Markets & Daily Oversold Stock Bounce Ideas - Улправда
Net debt of Mural Oncology Plc – LS:A3EE4M - TradingView — Track All Markets
Will Mural Oncology plc stock benefit from automation2026 world cup usa national team semifinals goalkeepers pressing system group prediction breakdown - Улправда
Return on invested capital % of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab - marketscreener.com
Drug royalties reshuffled as XOMA trades part of one for nine experimental drugs - Stock Titan
Net margin % of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
Current ratio of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc Earnings and Revenue – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.53%
2.69%
大文字化:
|
ボリューム (24 時間):